Frank Pitzer made chief executive at NimbleGen
April 7, 2010Research and Development NimbleGen, Roche, appointment, research and development
Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …
New consultancy Strategic North launched
April 7, 2010Medical Communications, Sales and Marketing Consultancy, coleiro, marketing, marketing ideas, strategy
A new healthcare industry marketing consultancy based in the North West of England has been launched. Strategic North is a …
Publicis acquires In-Sync
April 6, 2010Medical Communications agency, medical communications, publicis
Global communications group Publicis has acquired Toronto-based In-Sync, a company specialising in healthcare market research. In-Sync will become part of …
Manufacturing news in brief
April 6, 2010Manufacturing and Production NIB, Valeant, Warner Chilcott, baxter
This week’s round-up of recent developments in the pharmaceutical manufacturing arena sees a new facility build for Ireland’s HKPB and …
Conservative claims on cancer drugs disputed
April 6, 2010Sales and Marketing NHS, NICE, election
A think tank has disputed Conservative claims that funds can be diverted to pay for greater access to new cancer …
Warner Chilcott gets Actonel lift
April 6, 2010Sales and Marketing Sanofi, Warner Chilcott, actonel, osteoporosis
Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …
Talking Point: Responding to Trial Emergencies
April 6, 2010Research and Development
Unblinding is only done when it is deemed essential for the patients by the subject’s physician or a regulatory body, …
Biosimilars: the great balancing act
April 6, 2010Research and Development biogenerics, biosimilars
Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …
Obituary: Sir James Black
April 6, 2010Research and Development appointment, research and development
Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …
Catherine Warne made chief executive at Red Door
April 6, 2010Medical Communications Creston, Red Door, appointment, medical communications
Red Door has made Catherine Warne chief executive as part of a reorganisation that also sees promotions for Catherine Oliver, …
Pfizer first to disclose trial payments
April 1, 2010Research and Development, Sales and Marketing Pfizer, industry reputation, payments
Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …
Roche’s Xeloda widens licence
April 1, 2010Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer
Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …
Historic US reforms favour pharma – for now at least
April 1, 2010Sales and Marketing Obama, US healthcare
The industry will be grateful for some certainty on the future market outlook and, overall, there is a strong belief …
New CRO Celerion rises out of MDS divestment
April 1, 2010Research and Development Celerion, mds
Celerion has completed the acquisition of MDS Pharma Services’ early-stage development and regulatory services business, marking the latter’s exit from …
Sanofi refocuses its French manufacturing capacity
April 1, 2010Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics
Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …
Chiltern Announces Investment in Endpoint
April 1, 2010Research and Development
Glenn Kerkhof, Chiltern CEO, stated, “Chiltern’s decision to invest in Endpoint is representative of our commitment to seek collaborations which …
PAN makes board promotions
April 1, 2010Medical Communications Creston, Pan, appointment, medical communications
PAN Advertising has promoted Ben Davies (pictured right) to chief executive as part of a trio of promotions within its …
Healthcare reform momentus for pharma too
April 1, 2010Obama, US, biosimilars, healthcare reform
Historic reforms of America’s healthcare system have now passed into law, representing its most radical overhaul ever. Nevertheless, the bill …
GSK signs RNA therapeutics alliance
March 31, 2010Research and Development GlaxoSmithKline, Isis, RNA
GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …
Generic substitution will not deliver significant NHS savings, says EMIG
March 31, 2010Sales and Marketing EMIG, NHS, generics
The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
